Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Pie charts showing the breakdown of the OTC market in Britain in 2016

A breakdown of the over-the-counter medicines market in Britain in 2016Subscription

The Pharmaceutical Journal, Vol 298, No 7900

The over-the-counter medicines market grew by 2.3% during 2016 to reach £2.62bn.

All Infographics

Diagram showing different pharmacy organisations in the UK and who they represent

Pharmacy organisations in the UK: a complicated webSubscription

Pharmacy is a diverse profession and this is reflected in the wide variety of organisations that can represent the interests of pharmacists, pharmacy owners, trainees and students. 

Infographic showing how dupilumab works

Atopic dermatitis: emerging and current treatments Subscription

Atopic dermatitis affects up to 30% of children and 10% of adults, and is common in both developed and developing countries. Two new medicines on the brink of entering the market — dupilumab, a biologic for severe disease, and crisaborole, a topical small molecule drug for milder disease — could herald a new era in the management of this condition, which has seen no major changes to the way it has been treated for over 15 years.

Infographic showing a decade of community pharmacy funding in England and timeline of events

A decade of community pharmacy funding in EnglandSubscription

Community pharmacies in England dispense 174 million more prescription items annually than in 2010, a figure that is predicted to rise further. Despite this, total funding for the community pharmacy contract is heading back towards 2010 levels.

Treatment targets of osteoporosis

Osteoporosis: moving beyond bisphosphonatesSubscription

Bisphosphonates are the mainstay of osteoporosis treatment but as more is elucidated about the underlying pathology of the condition, new drug targets are being investigated.

Cross section of the infographic showing leading providers of influenza vaccinations in English pharmacies

Leading providers of influenza vaccinations in pharmacies in EnglandSubscription

In 2015–2016, 7,195 pharmacies in England administered influenza vaccinations to almost 600,000 individuals as part of the first year of the national NHS Flu Vaccination Service, with some pharmacies delivering over 1,000 vaccinations.

Infographic on the new oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation

New oral anticoagulants for stroke prevention in atrial fibrillationSubscription

Around 12,500 strokes are caused by atrial fibrillation (AF) in the UK each year, and 7,100 of these are preventable with appropriate anticoagulation. Four new oral anticoagulants (NOACs) are now available in the UK in addition to warfarin.

Infographic explaining the pathology and treatment types of dry eye disease

Dry eye: pathology and treatment types

The underlying disease process in dry eye disease causes deterioration of the tear film, which leads to either mild or more serious forms of the condition. A variety of treatment types may offer symptomatic relief.

Infographic comparing the different dispensing models in community pharmacy

Dispensing: a comparison of different models in community pharmacySubscription

Although most medicines are still dispensed by hand, new technology allows parts of the process to be automated. This infographic compares examples of the newer models, such as hub and spoke and centralised dispensing, with the traditional model.

Timeline and infographic showing the development and safety of proton pump inhibitors

The development and safety of proton pump inhibitorsSubscription

Since the discovery of omeprazole in 1979, dispensing of proton pump inhibitors (PPIs) in England has increased more than 100-fold, and several products are now available without prescription. Although PPIs are effective and generally well tolerated, observational studies suggest an association with several adverse effects. Further trials are needed to establish causal relationships. 

Data visualisation of the fragmented community pharmacy market in Great Britain in 2016 showing ownership share and pharmacy premises

Community pharmacy in Great Britain 2016: a fragmented marketSubscription

There are more than 14,000 community pharmacies in Great Britain and the top 12 players own almost 50% of the market. 

Infographic showing the drug targets in rheumatoid arthritis

Blocking the immune system in rheumatoid arthritisSubscription

Rheumatoid arthritis is caused by the immune system attacking the body. It afflicts about 1% of people in the UK and is now treated with a variety of biologic drugs that dampen the immune system in different ways

Infographic on the breakdown of the total over-the-counter (OTC) market value in Britain in 2015

Sales of over-the-counter medicines in 2015 by clinical area and top 50 selling brandsSubscription

The over-the-counter products market grew by 2.5% in 2015 to reach £2.55bn, with painkillers accounting for 23.2% of sales, followed by cough and cold remedies (18.7%) and skin treatments (17.8%).

Infographic showing the origins of the zika outbreak and its potential threat

Origins of the Zika outbreak and its potential threat

Researchers are working to understand more about the Zika virus — how it is transmitted, its link to microcephaly and Guillain-Barré syndrome and whether a vaccine can be developed.

Targeting Hepatitis C: How new treatments work

Targeting hepatitis C — how new treatments workSubscription

There are >185 million people with hepatitis C infection worldwide but new treatments mean that most people with access to therapy can now be cured. 

Timeline of the evolution of community pharmacists in the UK from the 1800s to the present

The evolution of community pharmacists in the UKSubscription

Legal cases have helped to shape community pharmacy from its roots in the one-time competitive roles of apothecary and chemist and druggist.

A visual history of HIV survival in the UK

A history of HIV survival in the UKSubscription

Treatment for HIV has radically improved since the beginning of the epidemic in 1981. HIV-infected people in the UK are now surviving for decades, rather than months or years.

Impact and challenges of the flu virus

Effectiveness of the seasonal flu vaccine and new production methodsSubscription

Despite a mismatch between the 2014–2015 seasonal flu vaccine and circulating strains, the flu jab is still the best way to protect people in at-risk groups.

Oligomers are thought to be more damaging than plaques because they block cell-to-cell signalling at synapses and may also activate immune system cells triggering an attack. Neurofibrillary tangles form within nerve cells, while amyloid plaques build up i

Closing in on Alzheimer’s diseaseSubscription

Knowledge about the neuropathology of Alzheimer’s disease has blossomed over the past few decades, leading to a better understanding of the condition and new ways to attack it.

A range of anti-smoking policies and new cessation products has led to reduced rates of smoking in most countries, which will eventually impact on smoking-related deaths.

A decade of smoking cessation in EuropeSubscription

The continent with the worst smoking habit is gradually giving it up. A range of anti-smoking policies and new cessation products has led to reduced rates of smoking in most countries, which will eventually impact on smoking-related deaths.

The 20 largest research-based pharmaceutical companies are active in 75 developing countries in at least one of four areas: research and development; quality management in manufacturing; supply chain management; and pharmacovigilance.

Targeting disease in the developing worldSubscription

A new report by the Access to Medicine Index finds that pharmaceutical companies influence access to medicines in developing countries through the development of innovative and adapted products, operating equitable pricing strategies and building local capacity.

All Infographics